Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.
- NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_assertion description "[Results show a significant positive correlation between the concentrations of tissue VEGF and its receptor VEGFR2 in primary breast neoplasms during neoadjuvant therapy, and suggest that VEGFR2 levels may indicate the level of lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.
- NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_assertion evidence source_evidence_literature NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.
- NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_assertion SIO_000772 19023980 NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.
- NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_assertion wasDerivedFrom lhgdn-20090331 NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.
- NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_assertion wasGeneratedBy ECO_0000203 NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP209574.RAZ0IMSznwZi6QlxUApNH4H7hzRtgwuYQ2t51w9XUcqwY130_provenance.